Skip to main content

Ultragenyx Pharmaceu(RARE-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume
Day Low39.98
Day High42.07
Open:40.62
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Latest News

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire - Wed Aug 3, 3:05PM CDT
Globe Newswire
Wed Aug 3, 3:05PM CDT
NOVATO, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development...
Ultragenyx Reports Second Quarter 2022 Financial Results and Corporate Update
Globe Newswire - Thu Jul 28, 3:01PM CDT
Globe Newswire
Thu Jul 28, 3:01PM CDT
Second quarter 2022 total revenue of $89.3 million and Crysvita® revenue in Ultragenyx territories1 of $64.0 million Reaffirm 2022 Crysvita revenue in...
Ultragenyx to Host Conference Call for Second Quarter 2022 Financial Results and Corporate Update
Globe Newswire - Mon Jul 25, 3:01PM CDT
Globe Newswire
Mon Jul 25, 3:01PM CDT
NOVATO, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development...

Latest Articles